COVID tool accelerator is likely to continue through 2022


While COVID-19 surges continue to ride out across the world, the Access to COVID-19 Tools Accelerator (ACT-A) published today an independent strategic review looking at how it has made progress across its three pillars of diagnostics, therapeutics, and vaccines.

The World Health Organization (WHO) created ACT-A less than 3 months into the pandemic, and the report recommends that the program continue as long as global coordination around COVID-19 tools is valuable—in other words, the authors write, most likely through 2022.

Recommendations included an increased emphasis around downstream work to optimize the currently available tools, more equitable representation and participation with ACT-A (eg, more representatives from lower- and middle-income countries [LMICs]), and the creation of a data-sharing framework for programmatic and financial reporting.



read the full story